STERIS Net Profit Margin 2010-2022 | STE

Current and historical net profit margin for STERIS (STE) from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. STERIS net profit margin for the three months ending March 31, 2022 was .
STERIS Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $4.59B $0.24B 5.32%
2021-12-31 $4.25B $0.28B 6.57%
2021-09-30 $3.85B $0.25B 6.50%
2021-06-30 $3.41B $0.29B 8.39%
2021-03-31 $3.11B $0.40B 12.81%
2020-12-31 $3.06B $0.43B 14.20%
2020-09-30 $3.02B $0.42B 14.03%
2020-06-30 $3.00B $0.41B 13.75%
2020-03-31 $3.03B $0.41B 13.46%
2019-12-31 $2.98B $0.39B 13.21%
2019-09-30 $2.90B $0.34B 11.59%
2019-06-30 $2.84B $0.32B 11.20%
2019-03-31 $2.78B $0.30B 10.89%
2018-12-31 $2.73B $0.27B 9.85%
2018-09-30 $2.70B $0.32B 11.72%
2018-06-30 $2.65B $0.30B 11.43%
2018-03-31 $2.62B $0.29B 11.11%
2017-12-31 $2.59B $0.24B 9.40%
2017-09-30 $2.57B $0.14B 5.56%
2017-06-30 $2.58B $0.12B 4.61%
2017-03-31 $2.61B $0.11B 4.17%
2016-12-31 $2.62B $0.14B 5.38%
2016-09-30 $2.59B $0.17B 6.40%
2016-06-30 $2.44B $0.14B 5.54%
2016-03-31 $2.24B $0.11B 4.96%
2015-12-31 $2.05B $0.09B 4.58%
2015-09-30 $1.91B $0.11B 5.88%
2015-06-30 $1.88B $0.13B 7.14%
2015-03-31 $1.85B $0.14B 7.29%
2014-12-31 $1.81B $0.13B 7.33%
2014-09-30 $1.75B $0.12B 7.10%
2014-06-30 $1.67B $0.12B 7.37%
2014-03-31 $1.62B $0.13B 8.01%
2013-12-31 $1.59B $0.13B 8.32%
2013-09-30 $1.56B $0.15B 9.68%
2013-06-30 $1.53B $0.16B 10.51%
2013-03-31 $1.50B $0.16B 10.59%
2012-12-31 $1.46B $0.16B 11.07%
2012-09-30 $1.44B $0.15B 10.29%
2012-06-30 $1.43B $0.14B 9.68%
2012-03-31 $1.41B $0.14B 9.74%
2011-12-31 $1.40B $0.13B 9.46%
2011-09-30 $1.37B $0.12B 8.77%
2011-06-30 $1.34B $0.13B 9.42%
2011-03-31 $1.21B $0.05B 4.31%
2010-12-31 $1.16B $0.04B 3.70%
2010-09-30 $1.16B $0.06B 5.34%
2010-06-30 $1.16B $0.06B 4.99%
2010-03-31 $1.26B $0.13B 10.25%
2009-12-31 $1.27B $0.13B 10.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $21.113B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Integer Holdings (ITGR) United States $2.383B 18.51
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52